tradingkey.logo

Treace Medical Concepts Inc

TMCI

5.500USD

+0.160+3.00%
Market hours ETQuotes delayed by 15 min
346.32MMarket Cap
LossP/E TTM

Treace Medical Concepts Inc

5.500

+0.160+3.00%
More Details of Treace Medical Concepts Inc Company
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Company Info
Ticker SymbolTMCI
Company nameTreace Medical Concepts Inc
IPO dateApr 23, 2021
CEOMr. John T. Treace
Number of employees477
Security typeOrdinary Share
Fiscal year-endApr 23
Address100 Palmetto Park Place
CityPONTE VEDRA
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code32081
Phone19043735940
Websitehttps://www.treace.com/
Ticker SymbolTMCI
IPO dateApr 23, 2021
CEOMr. John T. Treace
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
72.42K
+85.77%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
53.38K
+12.38%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Richard W. Mott
Mr. Richard W. Mott
Lead Independent Director
Lead Independent Director
1.10M
+2.23%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
72.42K
+85.77%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
53.38K
+12.38%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Treace (John T.)
18.61%
Armistice Capital LLC
9.87%
BlackRock Institutional Trust Company, N.A.
5.41%
William Blair Investment Management, LLC
4.93%
The Vanguard Group, Inc.
4.30%
Other
56.88%
Shareholders
Shareholders
Proportion
Treace (John T.)
18.61%
Armistice Capital LLC
9.87%
BlackRock Institutional Trust Company, N.A.
5.41%
William Blair Investment Management, LLC
4.93%
The Vanguard Group, Inc.
4.30%
Other
56.88%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.90%
Investment Advisor/Hedge Fund
21.15%
Investment Advisor
19.72%
Hedge Fund
17.61%
Research Firm
3.05%
Bank and Trust
0.34%
Sovereign Wealth Fund
0.10%
Pension Fund
0.04%
Insurance Company
0.03%
Other
12.07%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
369
55.31M
87.93%
-19.85M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
2023Q1
265
55.41M
90.97%
+228.07K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Treace (John T.)
11.70M
18.61%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.21M
9.87%
+2.00K
+0.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.40M
5.41%
+14.71K
+0.43%
Mar 31, 2025
William Blair Investment Management, LLC
3.06M
4.87%
+121.76K
+4.14%
Mar 31, 2025
The Vanguard Group, Inc.
2.71M
4.3%
-27.56K
-1.01%
Mar 31, 2025
CIBC Private Wealth Management
2.29M
3.65%
+405.26K
+21.46%
Mar 31, 2025
Gagnon Securities LLC
2.71M
4.31%
+963.43K
+55.16%
May 09, 2025
Treace (James T)
1.78M
2.83%
--
--
Mar 24, 2025
JP Morgan Asset Management
1.40M
2.22%
-93.94K
-6.29%
Mar 31, 2025
DWS Investments UK Limited
1.28M
2.04%
-4.96K
-0.39%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares U.S. Medical Devices ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
Global X Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
View more
Franklin US Small Cap Multifactor Index ETF
Proportion0.04%
iShares U.S. Medical Devices ETF
Proportion0.03%
Fidelity Enhanced Small Cap ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI